ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2024

Serum Podoplanin Levels as a Potential Biomarker for Diabetic Nephropathy Progression: A Cross-Sectional Study.

Feng Huan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.